Two Sigma Investments
AIM

Two Sigma Investments’s AIM ImmunoTech AIM Stock Holding History

Two Sigma Investments’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1
Closed -$9K – 2458
2014
Q2 		$9K Buy
+1
New +$17.9K ﹤0.01% 2112
2013
Q3 		– Hold
0
– -$3K – 2423
2013
Q2 		– Hold
0
– – – 1941

Other funds holding AIM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OAM
Occidental Asset Management Burlingame, California $844M AUM 20.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments's AIM Position: Q3 2014 in Review

Two Sigma Investments sold out of AIM ImmunoTech (AIM) in Q3 2014, closing a stake of 1 share — an estimated $9K sold.

Two Sigma Investments first reported a position in AIM in Q2 2014 and held it in 1 quarter. The position peaked at $9K in Q2 2014. 14 funds tracked by Wall St. Rank hold AIM as of Q3 2014.

  • Two Sigma Investments reported no remaining AIM ImmunoTech position as of Q3 2014 after selling out during the quarter.
  • Two Sigma Investments sold 1 AIM ImmunoTech share in Q3 2014, an estimated $9K.
  • Two Sigma Investments first reported a position in AIM ImmunoTech in Q2 2014 and held it in 1 quarter.
  • Two Sigma Investments's AIM ImmunoTech position peaked at $9K in Q2 2014.
  • 14 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q3 2014.

Based on Two Sigma Investments's 13F filing for Q3 2014, filed 14 Nov 2014.